Cardiac complications as initial manifestation of pheochromocytoma: Frequency, outcome, and predictors

Endocrine Practice

Volumn 18, Issue 4, 2012, Pages 483-492

  Yu, Run ^a   Nissen, Nicholas N ^a   Bannykh, Serguei I ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART FAILURE; ADOLESCENT; ADRENALECTOMY; ADULT; AGED; ANXIETY; ARTICLE; CARDIOVASCULAR RISK; CHILD; CLINICAL FEATURE; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CONVALESCENCE; CYTOREDUCTIVE SURGERY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DISEASE SEVERITY; FEMALE; HEART ARRHYTHMIA; HEART DISEASE; HEART EJECTION FRACTION; HEART FUNCTION; HEART INFARCTION; HEART PALPITATION; HEART VENTRICLE THROMBOSIS; HUMAN; HUMAN TISSUE; HYPERTENSION; HYPERTENSIVE CRISIS; INCIDENTAL FINDING; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MITRAL VALVE REGURGITATION; OUTCOME ASSESSMENT; PARAGANGLIOMA; PHEOCHROMOCYTOMA; QT INTERVAL; SCHOOL CHILD; SYNCOPE; TUMOR VOLUME; UNITED STATES;

ADRENAL GLAND NEOPLASMS; ADULT; DECISION TREES; DELAYED DIAGNOSIS; FEMALE; FOLLOW-UP STUDIES; HEART DISEASES; HUMANS; HYPERTENSION; INCIDENCE; LONG QT SYNDROME; LOS ANGELES; MALE; MEDICAL RECORDS; MIDDLE AGED; PARAGANGLIOMA; PHEOCHROMOCYTOMA; SEVERITY OF ILLNESS INDEX; STROKE VOLUME; TUMOR BURDEN;

EID: 84864675740     PISSN: 1530891X     EISSN: 19342403     Source Type: Journal    
DOI: 10.4158/EP11327.OR     Document Type: Article

References (26)

1. Bravo EL, Tagle R. Pheochromocytoma: state-of-the-art and future prospects. Endocr Rev. 2003;24:539-553.
2. Manger WM. An overview of pheochromocytoma: his-tory, current concepts, vagaries, and diagnostic challenges. Ann N Y Acad Sci. 2006;1073:1-20.
3. Yu R, Nissen NN, Chopra P, Dhall D, Phillips E, Wei M. Diagnosis and treatment of pheochromocytoma in an aca-demic hospital from 1997 to 2007. Am J Med. 2009;122: 85-95.
4. Kassim TA, Clarke DD, Mai VQ, Clyde PW, Mohamed Shakir KM. Catecholamine-induced cardiomyopathy Endocr Pract. 2008;14:1137-1149.
5. Yu R, Furmark L, Wong C. Cardiac abnormalities asso-ciated with pheochromocytoma and other adrenal tumors. Endocr Pract. 2009;15:10-16.
6. Galetta F, Franzoni F, Bernini G, et al. Cardiovascular complications in patients with pheochromocytoma: a mini-review. Biomed Pharmacother. 2010;64:505-509.
7. Prejbisz A, Lenders JW, Eisenhofer G, Januszewicz A. Cardiovascular manifestations of phaeochromocytoma. J Hypertens. 2011;29:2049-2060.
8. Samaan NA, Hickey RC, Shutts PE. Diagnosis, localiza-tion, and management of pheochromocytoma: pitfalls and follow-up in 41 patients. Cancer. 1988;62:2451-2460.
9. Goldstein RE, O'Neill JA Jr, Holcomb GW III, et al. Clinical experience over 48 years with pheochromocytoma. Ann Surg. 1999;229:755-764.
10. Patócs A, Karádi E, Tóth M, et al. Clinical and biochemi-cal features of sporadic and hereditary phaeochromocyto-mas: an analysis of 41 cases investigated in a single endo-crine centre. Eur J Cancer Prev. 2004;13:403-409.
11. Dalby MC, Burke M, Radley-Smith R, Banner NR. Pheochromocytoma presenting after cardiac transplanta-tion for dilated cardiomyopathy J Heart Lung Transplant. 2001;20:773-775.
12. Vandwalle J, Spie R, Jarry G, Agaesse V, Petit J, Saint F. Pheochromocytoma and cardiogenic failure: an indication for emergency adrenalectomy in French. Prog Urol. 2010;20:498-502.
13. Yu R, Nissen NN, Dhall D, Phillips E. Diagnosis and management of pheochromocytoma in an academic hospi-tal 3 years after formation of a pheochromocytoma interest group. Endocr Pract. 2011;17:356-362.
14. Buchbinder NA, Yu R, Rosenbloom BE, Sherman CT, Silberman AW. Left ventricular thrombus and embolic stroke caused by a functional paraganglioma. J Clin Hypertens (Greenwich). 2009;11:734-737.
15. Milanesi A, Ho A, Ewing A, Yu R. Bilateral pheochro-mocytoma presenting as acute shortness of breath after job loss. Endocr Pract. 2011;17:307-308.
16. Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfeld MM. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med. 2006;355:251-259.
17. Ulchaker JC, Goldfarb DA, Bravo EL, Novick AC Successful outcomes in pheochromocytoma surgery in the modern era. J Urol. 1999;161:764-767.
18. Pacak K. Preoperative management of the pheochromocy-toma patient. J Clin Endocrinol Metab. 2007;92:4069-4079.
19. Wong C, Yu R. Preoperative preparation for pheochromo-cytoma resection: physician survey and clinical practice. Exp Clin Endocrinol Diab. 2010;118:400-404.
20. Pacak K, Eisenhofer G, Ahlman H, et al (International Symposium on Pheochromocytoma). Pheochromo-cytoma: recommendations for clinical practice from the First International Symposium; October 2005. Nat Clin Pract Endocrinol Metab. 2007;3:92-102.
21. Lenders JW, Pacak K, Walther MM, et al. Biochemical diagnosis of pheochromocytoma: which test is best? JAMA. 2002;287:1427-1434.
22. Yu R. Ordering pattern and performance of biochemical tests for diagnosing pheochromocytoma between 2000 and 2008. Endocr Pract. 2009;15:313-321.
23. Young WF Jr. Clinical practice: the incidentally discov-ered adrenal mass. N Engl J Med. 2007;356:601-610.
24. Wilcox CS, Aminoff MJ. Blood pressure responses to nor-adrenaline and dopamine infusions in Parkinson's disease and the Shy-Drager syndrome. Br J Clin Pharmacol. 1976; 3:207-214.
25. Bravo EL, Tarazi RC, Gifford RW, Stewart BH. Circulating and urinary catecholamines in pheochromo-cytoma: diagnostic and pathophysiologic implications. N Engl J Med 1979;301:682-686.
26. Mori H, Ishikawa S, Kojima S, et al. Increased respon-siveness of left ventricular apical myocardium to adrener-gic stimuli. Cardiovasc Res. 1993;27:192-198.